Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 18, 2022
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
[ Tue, Oct 18th 2022
] - WOPRAI
Matt Miksic Initiated (BSX) at Buy and Held Target at $49 on, Oct 18th, 2022
Matt Miksic of Barclays, Initiated "Boston Scientific Corporation" (BSX) at Buy and Held Target at $49 on, Oct 18th, 2022.
Matt has made no other calls on BSX in the last 4 months.
There are 8 other peers that have a rating on BSX. Out of the 8 peers that are also analyzing BSX, 0 agree with Matt's Rating of Hold.
These are the ratings of the 8 analyists that currently disagree with Matt
- Matthew Taylor of "Jefferies" Initiated at Strong Buy and Held Target at $50 on, Wednesday, October 12th, 2022
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $50 on, Tuesday, October 11th, 2022
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Increased Target to $50 on, Friday, September 9th, 2022
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Decreased Target to $48 on, Thursday, July 28th, 2022
- Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $50 on, Thursday, July 28th, 2022
- Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, July 20th, 2022
- Mike Polark of "Wolfe Research" Initiated at Buy on, Wednesday, July 6th, 2022
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $43 on, Wednesday, June 29th, 2022
